clinical trial · NCT05327530
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
EMD Serono Research & Development Institute, Inc.·phase2·active not recruiting·n = 256
Locally Advanced or Metastatic Urothelial CarcinomaAvelumabSacituzumab GovitecanM6223NKTR-255
brief summary
The purpose of this study is to assess the safety and efficacy of avelumab in combination with other anti-tumor agents as a maintenance treatment in participants with bladder cancer.
started
Aug 17, 2022
primary completion
Jun 20, 2025
completion
Jun 25, 2026
last updated
Apr 24, 2026
official title
A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination With Other AntiTumor Agents as a Maintenance Treatment in Participants With Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress With First Line Platinum-Containing Chemotherapy (JAVELIN Bladder Medley)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol